Biobetters Global Market is Booming Across the Globe and Witness Huge Growth By Key Players To 2033
Overview and Scope
Biobetters refer to biologic drugs that are similar to existing biologics but
have been enhanced to offer improved efficacy, safety, or other clinical
benefits. These improvements can include better dosing regimens, reduced side
effects, increased stability, or more convenient administration methods,
providing a competitive advantage over the original biologics.
Sizing and Forecast
The biobetters market size has grown rapidly in recent years. It will grow from
$60.73 billion in 2023 to $67.81 billion in 2024 at a compound annual growth
rate (CAGR) of 11.7%. The growth in the historic period can be attributed to
increased understanding of disease mechanisms, growing healthcare expenditure,
enhanced manufacturing technologies, technological innovations in drug
delivery, advancements in protein engineering, increased demand for improved
therapeutic efficacy.
The biobetters market size is expected to see rapid growth in the next few years.
It will grow to $105.94 billion in 2028 at a compound annual growth rate (CAGR)
of 11.8%. The growth in the forecast period can be attributed to advancements
in biotechnology, growing emphasis on personalized medicine, expanding
pipelines of biopharmaceutical companies, rising prevalence of chronic
diseases, favorable regulatory landscapes, heightened investments in research
and development, advance healthcare infrastructure. Major trends in the
forecast period include development of novel biobetters , protein engineering
and rational design, focus on therapeutic areas, advanced healthcare
infrastructure, development of next-generation sequencing (NGS) technologies
,advances in high-throughput screening (HTS) technologies.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/biobetters-global-market-report
Segmentation & Regional Insights
The biobetters market covered in this report is segmented –
1) By Drug Class: Erythropoietin Biobetters, Granulocyte-Colony Stimulating
Factor (G-CSF) Bioreactors, Interferon Biobetters, Insulin Biobetters,
Monoclonal Antibodies Biobetters, Antihemophilic Factors, Other Drug Classes
2) By Route of Administration: Oral, Subcutaneous, Inhaled, Intravenous, Other
Routes
3) By Disease Indication: Diabetes, Cancer, Renal Disease, Neurodegenerative
Diseases, Genetic Disorder-Hemophilia, Other Diseases
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online
Pharmacies
North America was the largest region in the biobetters market in 2023.
Asia-Pacific is expected to be the fastest-growing region in the forecast
period. The regions covered in the biobetters market report are Asia-Pacific,
Western Europe, Eastern Europe, North America, South America, Middle East,
Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the
report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15522&type=smp
Major Driver Impacting Market Growth
The rising incidence of chronic kidney diseases is expected to propel the
growth of the biobetters market going forward. Chronic kidney disease (CKD) is
defined as a long-term illness that causes the kidneys to malfunction and
eventually stop functioning. The prevalence of chronic kidney disease (CKD) is
increasing due to aging demographics, elevated incidences of diabetes and
hypertension, poor dietary habits, sedentary lifestyles, environmental
pollution, and enhanced diagnostic capabilities. Biobetters help in the
management of chronic kidney disease (CKD) by offering enhanced efficacy,
reduced side effects, better dosing regimens, and improved stability compared
to original biologic treatments, leading to better patient outcomes. For
instance, according to the Australian Institute of Health and Welfare (AIHW),
an Australia-based government agency for public health, in 2021, approximately
20,000 fatalities in Australia were linked to chronic kidney disease,
accounting for 12% of the total mortality rate in 2021. Therefore, the rising
incidence of chronic kidney diseases is driving the growth of the biobetters
market.
Impact Of Autoimmune Diseases On The Biobetters Market
The increasing prevalence of autoimmune diseases is expected to propel the
growth of the biobetters market going forward. Autoimmune diseases are
disorders that occur when an organism's immune system unintentionally attacks
healthy cells. Autoimmune diseases are increasing due to various factors,
including genetic predisposition, environmental influences, and lifestyle
changes. Biobetters help in autoimmune disorders by providing enhanced
efficacy, reduced side effects, improved dosing regimens, and increased
stability compared to original biologic treatments, leading to more effective
and tolerable management of these conditions. For instance, in December 2023,
according to the Australian Institute of Health and Welfare (AIHW), an
Australia-based government agency for public health, rheumatoid arthritis
comprised 2.0% of the total disease burden in 2023. In 2021, it led to 1,145
deaths, equivalent to 3.2 deaths per 100,000 people, accounting for 0.7% of all
fatalities. Therefore, the increasing prevalence of auto-immune diseases is
driving the growth of the biobetters market.
Key Industry Players
Major companies operating in the biobetters market are Pfizer Inc., Johnson & Johnson, Merck
& Co Inc., AbbVie Inc., Bayer AG, Sanofi Aventis LLC, Bristol-Myers Squibb
Company, Novartis AG, GlaxoSmithKline plc, F Hoffmann La Roche Ltd., Eli Lilly
and Co Ltd., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries
Ltd., Regeneron Pharmaceuticals Inc, CSL Behring GmbH, Biogen Inc., GRIFOLS USA
LLC, Celltrion Inc., Lonza Group AG, Ionis Pharmaceuticals Inc., Incyte
Corporation, Amicus Therapeutics Inc., Genentech Inc., Sun Pharmaceutical
Industries
The biobetters market report table of contents includes:
1. Executive Summary
2. Biobetters Market Characteristics
3. Biobetters Market Trends And Strategies
4. Biobetters Market - Macro Economic Scenario
5. Global Biobetters Market Size and Growth
.....
32. Global Biobetters Market Competitive Benchmarking
33. Global Biobetters Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Biobetters Market
35. Biobetters Market Future Outlook and Potential Analysis
36. Appendix
Explore the trending research reports from TBRC:
https://topprnews.com/gluten-feed-market
https://topprnews.com/organic-feed-market
https://topprnews.com/organic-pigments-market
https://goodprnews.com/rapeseed-oil-market
https://goodprnews.com/gluten-feed-market
https://goodprnews.com/manufactured-soil-market
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info
Healthcare Blog: https://healthcareresearchreports.com
Comments
Post a Comment